EAI Test Predicts Benefit From Extended Breast Cancer Therapy
HOUSTON, Texas, Feb. 16, 2026 — New data presented at the 2025 San Antonio Breast Cancer Symposium (SABCS) reveal...
SABCS 2025
Advertisement
Elacestrant Phase 2 Combo Data Shows Strong PFS in ER+ mBC
FLORENCE, Italy and NEW YORK, December 8, 2025 — The Menarini Group and its oncology subsidiary Stemline Therapeutics unveiled...
Guardant Unveils New Multiomic Liquid Biopsy Insights at SABCS 2025
PALO ALTO, CA — December 5, 2025 — Guardant Health announced it will present 14 abstracts at the 2025...
BriaCell Reveals New Phase 2 and Phase 3 Data Ahead of SABCS 2025
Philadelphia, PA and Vancouver, BC — December 2, 2025 — BriaCell Therapeutics Corp. announced plans to present three major...
Anixa Biosciences Completes Final Patient Visit in Breast Cancer Vaccine Trial
SAN JOSE, Calif., October 7, 2025 – Anixa Biosciences, Inc. (NASDAQ: ANIX), a clinical-stage biotechnology company dedicated to cancer...
Advertisement
